The plasma master file (PMF) is a compilation of all the required scientific data on the quality and safety of human plasma relevant to the medicines, medical devices and investigational products that use human plasma in their manufacture. These data cover all aspects of the use of plasma, from collection to plasma pool.
The concept of the PMF was established by European legislation in June 2003.
The PMF is a separate set of documentation from the dossier for a medicine's marketing authorisation.
The first step of the PMF certification procedure is similar to the marketing-authorisation evaluation procedure. Following the satisfactory outcome of an evaluation, the Agency issues a PMF certificate of compliance with European legislation. This certificate is valid throughout the European Union.
In the second step, after certification, it is the responsibility of the marketing-authorisation holder to update its medicinal product licences and to incorporate the certified PMF in its marketing authorisations.
A summary of the quality and safety of the plasma is available in the European public assessment report (EPAR) for medicines that have been evaluated by the Agency and authorised by the European Commission.
- Procedural guidelines
- Dossier requirements
- Electronic application
- General information for applicants
- Background documents
- Coordinators list
How useful is this page?
Average rating:Based on 12 ratings
Add your rating:
- See all ratings
5 ratings1 ratings0 ratings3 ratings3 ratings